Rutherford Cross Retained to Appoint Finance Business Partner with Piramal Pharma Solutions

Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing (CDMO) organisation offering end-to-end development and manufacturing solutions across the drug life cycle. The company serves customers through a globally integrated network of facilities in North America, Europe, and Asia.

In Scotland, Piramal has development and manufacturing operations in Grangemouth generating revenues of c£48m. The newly built multipurpose state-of-the-art Antibody-Drug Conjugate (ADC) manufacturing and aseptic fill / finish facility provides scope for further growth. This expansion has been driven by several pipeline products moving to commercial scale, coupled with increased customer demand for ADCs and APIs. These two expansions represent a total investment of £55 million, generating local employment opportunities for skilled workers. In addition, Piramal is continually seeking and assessing new commercial opportunities that may well take expansion plans well beyond those already set.

Given the current size of the business and with potential opportunities to grow further, Piramal is now seeking to recruit a Finance Business Partner for the Grangemouth operation to support the Finance Director.

The Finance Business Partner will be a key part of the finance function, working alongside management to support the delivery of site business objectives. This will include understanding the drivers of long-term profitability to facilitate decision-making in areas such as contract profitability, inventory and capital expenditure. The Finance Business Partner will provide managers with insightful financial analysis and ensure finance processes are delivered efficiently.

For any questions, contact Jonathan Donnelly at [email protected]